Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Use of non-steroidal anti-inflammatory drugs and associated gastroprotection in a cohort of workers

  • Lallana, M.J.
  • Feja, C.
  • Aguilar-Palacio, I.
  • Malo, S.
  • Rabanaque, M.J.
Background: This study describes the prevalence of non-steroidal anti-inflammatory drug (NSAID) use, and analyses prescribing patterns of NSAIDs and associated gastroprotection. Methods: The study population consisted of 5650 workers at the General Motors automobile assembly plant in Zaragoza, Spain. NSAID prescription data for 2014 were obtained from the prescription database of Aragon (Spain). NSAID consumption was determined based on the number of defined daily doses purchased per year. Heavy NSAIDs users were identified using Lorenz curves. Results: NSAID use in the cohort was high (40.7% of workers, 95% CI 39.4–41.9). The prescription of proton pump inhibitors increased with age. Gastrointestinal protection was lacking in some participants who were being treated with drugs associated with a high risk of gastrointestinal bleeding. Heavy NSAID users (defined as those above the 95th percentile of consumption), accounted for 26% of total DDDs, and consumed a greater proportion of coxibs than non-heavy users. Conclusions: The rate of NSAID consumption in the cohort was high. To reduce the risk of gastrointestinal complications, monitoring and adequate gastroprotection are essential in patients who are prescribed NSAIDs for long periods of time or who are treated concomitantly with drugs that increase the risk of gastrointestinal bleeding.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Otros (Other)

Addendum: Lallana, M.J. et al. Use of Non-Steroidal Anti-Inflammatory Drugs and Associated Gastroprotection in a Cohort of Workers. 2018, 15, 1836

  • Lallana, M.J.
  • Feja, C.
  • Aguilar-Palacio, I.
  • Malo, S.
  • Rabanaque, M.J.
The authors wish to make the following correction to this paper [1]: Change in Funding In the original version of our article (Lallana, M.J. et al. Use of Non-Steroidal Anti-Inflammatory Drugs and Associated Gastroprotection in a Cohort of Workers. 2018, 15, 1836), insufficient source of funding was given. The authors wish to change the information in the Funding section from: Funding: This study was funded by the Instituto Carlos III, grant number (PI17/01704). to the correct version as follows: Funding: This study was funded by Proyecto del Fondo de Investigación Sanitaria, Instituto de Salud Carlos III (Ministerio de Ciencia e Innovación) and Fondo Europeo de Desarrollo Regional (FEDER)(PI17/011704). The authors would like to apologize for any inconvenience caused to the readers by these changes.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Pharmacological primary cardiovascular prevention and subclinical atherosclerosis in men: Evidence from the aragon workers'' health study

  • Aguilar-Palacio, Isabel
  • Malo, Sara
  • Jarauta, Estibaliz
  • Moreno-Franco, Belén
  • Maldonado, Lina
  • Compés, Luisa
  • Rabanaque, José
  • Casasnovas, José Antonio
The objective of this study is to describe the profile of primary preventive treatment for cardiovascular disease in adult males and to analyze the association between treatment profile and subclinical atherosclerosis. We selected male workers who had undergone ultrasound imaging and had no previous history of cardiovascular disease (n = 2138). Data on the consumption of primary cardiovascular drugs from the previous year were obtained. We performed bivariate analyses to compare patient characteristics according to cardiovascular treatment and the presence of subclinical atherosclerosis, and logistic regression models to explore the association between these two variables. Among participants with no personal history of cardiovascular disease, subclinical atherosclerosis was present in 77.7% and 31.2% had received some form of preventive treatment. Of those who received no preventive treatment, 73.6% had subclinical atherosclerosis. Cardiovascular preventive treatment was associated only with CACS > 0 (odds ratio (OR), 1.37; 95% confidence interval (95% CI), 1.06-1.78). Statin treatment was associated with a greater risk of any type of subclinical atherosclerosis (OR, 1.73) and with CACS > 0 (OR, 1.72). Subclinical atherosclerosis existed in almost 75% of men who had no personal history of cardiovascular disease and had not received preventive treatment for cardiovascular disease.